News Help Institutional access
Back to results
Bibliographic record · Consultation and access
Artículo

Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications

Palomo, Addys González et al · Springer · 2016

Open-access full text
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.
Author / responsible party
Palomo, Addys González et al
Publisher
Springer
Year
2016
ISSN
0262-0898
ISSN
0262-0898
Language
English

Resource access

Open the content from the main option or choose another available source.

CONICET Digital CONICET Digital OAI-PMH
Entrar por CONICET Digital
Main access

Open-access full text

Texto completo identificado como acceso abierto.
Open text

Summary

Descripción general del contenido del recurso.

Interaction between epidermal growth factor receptor (EGFR) signaling with GM3 ganglioside expression has been previously described. However, little is known about EGFR and NeuGcGM3 co-expression in cancer patients and their therapeutic implications. In this paper, we evaluate the co-expression of EGFR and NeuGcGM3 ganglioside in tumors from 92 patients and in two spontaneous lung metastasis models of mice (Lewis lung carcinoma (3LL-D122) in C57BL/6 and mammary carcinoma (4T1) in BALB/c). As results, co-expression of EGFR and NeuGcGM3 ganglioside was frequently observed in 63 of 92 patients (68 %), independently of histological subtype. Moreover, EGFR is co-expressed with NeuGcGM3 ganglioside in the metastasis of 3LL-D122 and 4T1 murine models. Such dual expression appears to be therapeutically relevant, since combined therapy with mAbs against these two molecules synergistically increase the survival of mice treated. Overall, our results suggest that NeuGcGM3 and EGFR may coordinately contribute to the tumor cell biology and that therapeutic combinations against these two targets might be a valid strategy to explore. Fil: Palomo, Addys González. Centro de Inmunología Molecular; Cuba Fil: Santana, Rancés Blanco. Centro de Inmunología Molecular; Cuba

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

Palomo, A. G. E. A. (2016). Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications. http://hdl.handle.net/11336/90950

MLA

Palomo, Addys González et al. "Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications." 2016. http://hdl.handle.net/11336/90950.

Chicago

Palomo, Addys González et al. 2016. "Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications.". http://hdl.handle.net/11336/90950.

Harvard

Palomo, A. G. E. A. 2016, Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications, Springer, available at: http://hdl.handle.net/11336/90950 [Accessed 5 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

RIS BibTeX

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications
Author / contributors
Palomo, Addys González et al
Publisher
Springer
Publication year
2016
ISSN
0262-0898
ISSN
0262-0898
Language
English

Subjects

Explore related resources through these subjects.

Co-expression; Combination therapy; EGFR; NeuGcGM3; Pulmonary metastasis; https://purl.org/becyt/ford/1.6; https://purl.org/becyt/ford/1
Copied